Author:
C. Carney Bonnie,W. Shupp Jeffrey,E. Travis Taryn
Abstract
Hypertrophic scar (HTS) is a fibrotic skin disorder that is marked by excessive inflammation and extracellular matrix deposition in response to cutaneous traumatic injuries such as burns, lacerations, incisions, and abrasions. HTS has various risk factors, available treatments, and treatment effectiveness. Research at the basic, translational, and clinical levels are in their infancy compared to fibrotic diseases in other organ systems. This chapter will review current in vitro and in vivo modeling, and highlight research needs to address gaps in the study of HTS. The following topics will be discussed in the chapter: a. Basic Science Research i. Seminal findings ii. Limitations to these models iii. Suggestions for topics of future research b. Translational Science Research i. Seminal findings ii. Limitations to these models iii. Suggestions for topics of future research c. Clinical Research i. Seminal findings ii. Limitations to these models iii. Suggestions for topics of future research.
Reference257 articles.
1. Limandjaja, G.C., et al., Increased epidermal thickness and abnormal epidermal differentiation in keloid scars . Br J Dermatol, 2017. 176(1): p. 116-126.
2. Yang, S., et al., Abnormalities in the basement membrane structure promote basal keratinocytes in the epidermis of hypertrophic scars to adopt a proliferative phenotype . Int J Mol Med, 2016. 37(5): p. 1263-1273.
3. Kischer, C.W., A.C. Thies, and M. Chvapil, Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids . Hum Pathol, 1982. 13(9): p. 819-824.
4. Kischer, C.W. and M.R. Shetlar, Microvasculature in hypertrophic scars and the effects of pressure . J Trauma, 1979. 19(10): p. 757-764.
5. Ehrlich, H.P., et al., Morphological and immunochemical differences between keloid and hypertrophic scar . Am J Pathol, 1994. 145(1): p. 105-113.